Example: Heart Attack

Clinical Trials on Intestinal Transporter Expression

Total 10000 results

NCT00810303

Completed

Pharmacokinetic and Pharmacodynamic Interactions Between the Cholesterol-lowering Ezetimibe and the Non-nucleoside Reverse Transcriptase Inhibitor Efavirenz During Chronic Treatment in Healthy Volunteers With Reference to Intestinal Expression of CYP3A4, UGT1A1, ABCB1 and ABCC2

Pharmacokinetics | Pharmacodynamics | Drug Interactions | Intestinal Transporter Expression
NCT03041363

Completed

Treatment Development of Triheptanoin (G1D)

Glucose Metabolism Disorders | Epilepsy | Glucose Transporter Type 1 Deficiency Syndrome | Glut1 Deficiency Syndrome 1, Autosomal Recessive | Glucose Transporter Protein Type 1 Deficiency Syndrome | Glucose Transport Defect | GLUT1DS1
NCT03181399

Completed

Diet Treatment Glucose Transporter Type 1 Deficiency (G1D)

Glucose Metabolism Disorders | Epilepsy | Glucose Transporter Type 1 Deficiency Syndrome | Glut1 Deficiency Syndrome 1, Autosomal Recessive | Glucose Transporter Protein Type 1 Deficiency Syndrome | Glucose Transport Defect | GLUT1DS1
NCT06018519

Recruiting

Relevant Outcome Measures for Creatine Transporter Deficiency Patient (CREAT_criteria)

Creatine Transporter Defect
NCT02226419

Completed

Fat and Sugar Metabolism During Exercise, With and Without L-carnitine in Patients With Carnitine Transporter Deficiency (CTD)

Carnitine Transporter, Plasma-membrane, Deficiency of

This is a preview
Log in or create a free account to see all matching trials and use the full search.
Log in | Register